rs7154732

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001206673.2(ABHD12B):​c.1000T>C​(p.Phe334Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0406 in 1,614,048 control chromosomes in the GnomAD database, including 1,763 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.060 ( 399 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1364 hom. )

Consequence

ABHD12B
NM_001206673.2 missense

Scores

1
8
8

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.39

Publications

17 publications found
Variant links:
Genes affected
ABHD12B (HGNC:19837): (abhydrolase domain containing 12B) Predicted to enable acylglycerol lipase activity; lysophospholipase activity; and palmitoyl-(protein) hydrolase activity. Predicted to be involved in monoacylglycerol catabolic process and phosphatidylserine catabolic process. Predicted to be active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017242134).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001206673.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABHD12B
NM_001206673.2
MANE Select
c.1000T>Cp.Phe334Leu
missense
Exon 12 of 13NP_001193602.1Q7Z5M8-1
ABHD12B
NM_181814.2
c.769T>Cp.Phe257Leu
missense
Exon 10 of 11NP_861535.1Q7Z5M8-2
ABHD12B
NM_181533.4
c.679T>Cp.Phe227Leu
missense
Exon 11 of 12NP_853511.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABHD12B
ENST00000337334.7
TSL:1 MANE Select
c.1000T>Cp.Phe334Leu
missense
Exon 12 of 13ENSP00000336693.2Q7Z5M8-1
ABHD12B
ENST00000353130.5
TSL:1
c.769T>Cp.Phe257Leu
missense
Exon 10 of 11ENSP00000343951.1Q7Z5M8-2
PYGL
ENST00000532462.5
TSL:1
c.2379+4140A>G
intron
N/AENSP00000431657.1E9PK47

Frequencies

GnomAD3 genomes
AF:
0.0599
AC:
9116
AN:
152164
Hom.:
397
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0254
Gnomad ASJ
AF:
0.0331
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0306
Gnomad FIN
AF:
0.0548
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0397
Gnomad OTH
AF:
0.0421
GnomAD2 exomes
AF:
0.0407
AC:
10230
AN:
251342
AF XY:
0.0406
show subpopulations
Gnomad AFR exome
AF:
0.122
Gnomad AMR exome
AF:
0.0174
Gnomad ASJ exome
AF:
0.0352
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0532
Gnomad NFE exome
AF:
0.0413
Gnomad OTH exome
AF:
0.0359
GnomAD4 exome
AF:
0.0385
AC:
56333
AN:
1461768
Hom.:
1364
Cov.:
32
AF XY:
0.0387
AC XY:
28115
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.126
AC:
4234
AN:
33472
American (AMR)
AF:
0.0191
AC:
855
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
925
AN:
26124
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39698
South Asian (SAS)
AF:
0.0400
AC:
3448
AN:
86246
European-Finnish (FIN)
AF:
0.0503
AC:
2685
AN:
53418
Middle Eastern (MID)
AF:
0.0543
AC:
313
AN:
5768
European-Non Finnish (NFE)
AF:
0.0373
AC:
41451
AN:
1111928
Other (OTH)
AF:
0.0400
AC:
2414
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2775
5550
8326
11101
13876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1506
3012
4518
6024
7530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0599
AC:
9118
AN:
152280
Hom.:
399
Cov.:
32
AF XY:
0.0599
AC XY:
4458
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.122
AC:
5070
AN:
41542
American (AMR)
AF:
0.0254
AC:
389
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
115
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.0307
AC:
148
AN:
4828
European-Finnish (FIN)
AF:
0.0548
AC:
581
AN:
10606
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0397
AC:
2700
AN:
68016
Other (OTH)
AF:
0.0416
AC:
88
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
432
864
1296
1728
2160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0455
Hom.:
1969
Bravo
AF:
0.0596
TwinsUK
AF:
0.0369
AC:
137
ALSPAC
AF:
0.0348
AC:
134
ESP6500AA
AF:
0.127
AC:
559
ESP6500EA
AF:
0.0364
AC:
313
ExAC
AF:
0.0441
AC:
5354
Asia WGS
AF:
0.0230
AC:
82
AN:
3478
EpiCase
AF:
0.0373
EpiControl
AF:
0.0381

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.76
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Benign
1.9
L
PhyloP100
4.4
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-3.5
D
REVEL
Benign
0.17
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.011
D
Polyphen
0.98
D
Vest4
0.75
MutPred
0.40
Gain of catalytic residue at P335 (P = 0)
MPC
0.44
ClinPred
0.018
T
GERP RS
4.9
Varity_R
0.46
gMVP
0.67
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7154732; hg19: chr14-51370849; API